Convenio de Suministro Insulinas
SUMINISTRAR LOS FARMACOS NECESARIOS POR UN PERIODO DE TRES MESES.
4 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 2105-5353-SE16 | 01-08-2016 | Novo Nordisk Farmaceutica Limitada | $1.428.000 |
| 2105-4977-SE16 | 16-07-2016 | Novo Nordisk Farmaceutica Limitada | $1.428.000 |
| 2105-4958-SE16 | 15-07-2016 | Aventis Pharma Holding Gmbh | $3.895.108 |
| 2105-4237-SE16 | 17-06-2016 | Aventis Pharma Holding Gmbh | $3.895.108 |
| 2105-3317-SE16 | 11-05-2016 | Novo Nordisk Farmaceutica Limitada | $1.904.000 |
| 2105-3318-SE16 | 11-05-2016 | Aventis Pharma Holding Gmbh | $1.752.799 |
| 2105-2781-SE16 | 20-04-2016 | Novo Nordisk Farmaceutica Limitada | $2.856.000 |
| 2105-2782-SE16 | 20-04-2016 | Aventis Pharma Holding Gmbh | $3.213.464 |
| 2105-2192-SE16 | 24-03-2016 | Aventis Pharma Holding Gmbh | $3.408.220 |
| 2105-2191-SE16 | 24-03-2016 | Novo Nordisk Farmaceutica Limitada | $2.380.000 |
| 2105-1926-SE16 | 14-03-2016 | Aventis Pharma Holding Gmbh | $3.895.108 |
| 2105-1624-SE16 | 07-03-2016 | Novo Nordisk Farmaceutica Limitada | $2.380.000 |
| 2105-703-SE16 | 02-02-2016 | Aventis Pharma Holding Gmbh | $1.947.554 |
| 2105-702-SE16 | 02-02-2016 | Novo Nordisk Farmaceutica Limitada | $1.285.200 |
| 2105-368-SE16 | 18-01-2016 | Novo Nordisk Farmaceutica Limitada | $1.285.200 |
| 2105-369-SE16 | 18-01-2016 | Aventis Pharma Holding Gmbh | $3.408.220 |
| 2105-6928-SE15 | 30-12-2015 | Novo Nordisk Farmaceutica Limitada | $2.142.000 |
| 2105-6929-SE15 | 30-12-2015 | Aventis Pharma Holding Gmbh | $3.408.220 |
| 2105-6471-SE15 | 14-12-2015 | Aventis Pharma Holding Gmbh | $2.921.331 |
| 2105-6470-SE15 | 14-12-2015 | Novo Nordisk Farmaceutica Limitada | $1.904.000 |
| 2105-6100-SE15 | 20-11-2015 | Novo Nordisk Farmaceutica Limitada | $1.904.000 |
| 2105-6101-SE15 | 20-11-2015 | Aventis Pharma Holding Gmbh | $3.602.975 |
| 2105-5452-SE15 | 20-10-2015 | Aventis Pharma Holding Gmbh | $2.921.331 |
| 2105-5451-SE15 | 20-10-2015 | Novo Nordisk Farmaceutica Limitada | $1.666.000 |
| 2105-4898-SE15 | 14-09-2015 | Aventis Pharma Holding Gmbh | $1.947.554 |
| 2105-4897-SE15 | 14-09-2015 | Novo Nordisk Farmaceutica Limitada | $952.000 |
| 2105-4402-SE15 | 26-08-2015 | Aventis Pharma Holding Gmbh | $1.947.554 |
| 2105-4403-SE15 | 26-08-2015 | Novo Nordisk Farmaceutica Limitada | $1.666.000 |
| 2105-4030-SE15 | 03-08-2015 | Aventis Pharma Holding Gmbh | $2.921.331 |
| 2105-4029-SE15 | 03-08-2015 | Novo Nordisk Farmaceutica Limitada | $1.904.000 |
| 2105-3761-SE15 | 20-07-2015 | Novo Nordisk Farmaceutica Limitada | $1.904.000 |
| 2105-3762-SE15 | 20-07-2015 | Aventis Pharma Holding Gmbh | $2.921.331 |
| 2105-3451-SE15 | 08-07-2015 | Aventis Pharma Holding Gmbh | $2.434.443 |
| 2105-3452-SE15 | 08-07-2015 | Novo Nordisk Farmaceutica Limitada | $1.428.000 |
| 2105-2975-SE15 | 16-06-2015 | Aventis Pharma Holding Gmbh | $2.434.443 |
| 2105-2974-SE15 | 16-06-2015 | Novo Nordisk Farmaceutica Limitada | $1.428.000 |
| 2105-2395-SE15 | 12-05-2015 | Novo Nordisk Farmaceutica Limitada | $1.904.000 |
| 2105-2393-SE15 | 12-05-2015 | Aventis Pharma Holding Gmbh | $1.947.554 |
| 2105-2162-SE15 | 20-04-2015 | Aventis Pharma Holding Gmbh | $1.460.666 |
| 2105-2163-SE15 | 20-04-2015 | Novo Nordisk Farmaceutica Limitada | $1.428.000 |
| 2105-1829-SE15 | 09-04-2015 | Aventis Pharma Holding Gmbh | $1.460.666 |
| 2105-1830-SE15 | 09-04-2015 | Novo Nordisk Farmaceutica Limitada | $1.428.000 |
| 2105-1436-SE15 | 13-03-2015 | Novo Nordisk Farmaceutica Limitada | $952.000 |
| 2105-1438-SE15 | 13-03-2015 | Aventis Pharma Holding Gmbh | $1.947.554 |
| 2105-1009-SE15 | 18-02-2015 | Novo Nordisk Farmaceutica Limitada | $1.190.000 |
| 2105-992-SE15 | 17-02-2015 | Aventis Pharma Holding Gmbh | $2.434.443 |
| 2105-763-SE15 | 07-02-2015 | Novo Nordisk Farmaceutica Limitada | $1.190.000 |
| 2105-762-SE15 | 07-02-2015 | Aventis Pharma Holding Gmbh | $2.434.443 |
| 2105-363-SE15 | 21-01-2015 | Novo Nordisk Farmaceutica Limitada | $1.190.000 |
| 2105-362-SE15 | 21-01-2015 | Aventis Pharma Holding Gmbh | $2.190.998 |
| 2105-15-SE15 | 05-01-2015 | Aventis Pharma Holding Gmbh | $2.190.998 |
| 2105-14-SE15 | 05-01-2015 | Novo Nordisk Farmaceutica Limitada | $1.190.000 |
| 2105-6810-SE14 | 15-12-2014 | Novo Nordisk Farmaceutica Limitada | $1.071.000 |
| 2105-6809-SE14 | 15-12-2014 | Aventis Pharma Holding Gmbh | $1.460.666 |
| 2105-6363-SE14 | 03-12-2014 | Novo Nordisk Farmaceutica Limitada | $1.071.000 |
| 2105-6364-SE14 | 03-12-2014 | Aventis Pharma Holding Gmbh | $1.460.666 |
| 2105-5910-SE14 | 04-11-2014 | Aventis Pharma Holding Gmbh | $3.700.353 |
| 2105-5911-SE14 | 04-11-2014 | Novo Nordisk Farmaceutica Limitada | $2.380.000 |
| 2105-5249-SE14 | 06-10-2014 | Novo Nordisk Farmaceutica Limitada | $2.380.000 |
| 2105-5250-SE14 | 06-10-2014 | Aventis Pharma Holding Gmbh | $1.947.554 |
| 2105-4784-SE14 | 04-09-2014 | Novo Nordisk Farmaceutica Limitada | $2.856.000 |
| 2105-4785-SE14 | 04-09-2014 | Aventis Pharma Holding Gmbh | $4.381.997 |
| 2105-4536-SE14 | 21-08-2014 | Novo Nordisk Farmaceutica Limitada | $952.000 |
| 2105-4535-SE14 | 21-08-2014 | Aventis Pharma Holding Gmbh | $1.460.666 |
| 2105-4178-SE14 | 04-08-2014 | Aventis Pharma Holding Gmbh | $1.460.666 |
| 2105-4179-SE14 | 04-08-2014 | Novo Nordisk Farmaceutica Limitada | $952.000 |
| 2105-3874-SE14 | 14-07-2014 | Aventis Pharma Holding Gmbh | $1.947.554 |
| 2105-3756-SE14 | 10-07-2014 | Novo Nordisk Farmaceutica Limitada | $1.190.000 |
| 2105-3061-SE14 | 06-06-2014 | Aventis Pharma Holding Gmbh | $2.434.443 |
| 2105-3060-SE14 | 06-06-2014 | Novo Nordisk Farmaceutica Limitada | $1.666.000 |
| 2105-2441-SE14 | 26-05-2014 | Aventis Pharma Holding Gmbh | $1.947.554 |
| 2105-2439-SE14 | 26-05-2014 | Novo Nordisk Farmaceutica Limitada | $952.000 |
| 2105-2440-SE14 | 09-05-2014 | Aventis Pharma Holding Gmbh | $1.460.666 |
| 2105-2438-SE14 | 08-05-2014 | Novo Nordisk Farmaceutica Limitada | $952.000 |
| 2105-1751-SE14 | 17-04-2014 | Novo Nordisk Farmaceutica Limitada | $1.380.400 |
| 2105-1750-SE14 | 17-04-2014 | Aventis Pharma Holding Gmbh | $1.947.554 |
| 2105-1650-SE14 | 30-03-2014 | Novo Nordisk Farmaceutica Limitada | $1.380.400 |
| 2105-1651-SE14 | 30-03-2014 | Aventis Pharma Holding Gmbh | $1.850.176 |
| 2105-1234-SE14 | 14-03-2014 | Aventis Pharma Holding Gmbh | $1.460.666 |
| 2105-1233-SE14 | 14-03-2014 | Novo Nordisk Farmaceutica Limitada | $1.071.000 |
| 2105-889-SE14 | 25-02-2014 | Aventis Pharma Holding Gmbh | $1.460.666 |
| 2105-890-SE14 | 25-02-2014 | Novo Nordisk Farmaceutica Limitada | $952.000 |
| 2105-541-SE14 | 28-01-2014 | Aventis Pharma Holding Gmbh | $1.460.666 |
| 2105-542-SE14 | 28-01-2014 | Novo Nordisk Farmaceutica Limitada | $952.000 |
| 2105-6416-SE13 | 31-12-2013 | Aventis Pharma Holding Gmbh | $2.921.331 |
| 2105-6417-SE13 | 31-12-2013 | Novo Nordisk Farmaceutica Limitada | $1.904.000 |
| 2105-5795-SE13 | 29-11-2013 | Aventis Pharma Holding Gmbh | $2.921.331 |
| 2105-5794-SE13 | 29-11-2013 | Novo Nordisk Farmaceutica Limitada | $1.904.000 |
| 2105-5274-SE13 | 30-10-2013 | Novo Nordisk Farmaceutica Limitada | $1.428.000 |
| 2105-5275-SE13 | 30-10-2013 | Aventis Pharma Holding Gmbh | $1.655.421 |
| 2105-4703-SE13 | 02-10-2013 | Aventis Pharma Holding Gmbh | $2.921.331 |
| 2105-4704-SE13 | 02-10-2013 | Novo Nordisk Farmaceutica Limitada | $1.666.000 |
| 2105-4214-SE13 | 04-09-2013 | Aventis Pharma Holding Gmbh | $2.434.443 |
| 2105-4213-SE13 | 04-09-2013 | Novo Nordisk Farmaceutica Limitada | $1.904.000 |
| 2105-3683-SE13 | 08-08-2013 | Aventis Pharma Holding Gmbh | $2.044.932 |
| 2105-3684-SE13 | 08-08-2013 | Novo Nordisk Farmaceutica Limitada | $1.904.000 |
| 2105-3014-SE13 | 02-07-2013 | Novo Nordisk Farmaceutica Limitada | $1.904.000 |
| 2105-3015-SE13 | 02-07-2013 | Aventis Pharma Holding Gmbh | $2.434.443 |
| 2105-2405-SE13 | 28-05-2013 | Novo Nordisk Farmaceutica Limitada | $2.142.000 |
| 2105-2406-SE13 | 28-05-2013 | Aventis Pharma Holding Gmbh | $3.408.220 |
| 2105-1671-SE13 | 09-04-2013 | Aventis Pharma Holding Gmbh | $2.434.443 |
| 2105-1669-SE13 | 09-04-2013 | Novo Nordisk Farmaceutica Limitada | $1.523.200 |
| 2105-1139-SE13 | 05-03-2013 | Aventis Pharma Holding Gmbh | $2.921.331 |
| 2105-1140-SE13 | 05-03-2013 | Novo Nordisk Farmaceutica Limitada | $1.904.000 |
| 2105-925-SE13 | 21-02-2013 | Aventis Pharma Holding Gmbh | $2.434.443 |
| 2105-924-SE13 | 21-02-2013 | Novo Nordisk Farmaceutica Limitada | $1.666.000 |
| 2105-576-SE13 | 29-01-2013 | Novo Nordisk Farmaceutica Limitada | $1.904.000 |
| 2105-6844-SE12 | 28-12-2012 | Novo Nordisk Farmaceutica Limitada | $1.666.000 |
| 2105-6845-SE12 | 28-12-2012 | Aventis Pharma Holding Gmbh | $2.921.331 |
| 2105-6479-SE12 | 12-12-2012 | Aventis Pharma Holding Gmbh | $2.921.331 |
| 2105-6290-SE12 | 27-11-2012 | Novo Nordisk Farmaceutica Limitada | $1.904.000 |
| 2105-5748-SE12 | 22-10-2012 | Aventis Pharma Holding Gmbh | $2.921.331 |
| 2105-5747-SE12 | 22-10-2012 | Novo Nordisk Farmaceutica Limitada | $1.904.000 |
Fuente original:ficha mercadopublico.cl
